Paper Review Records
全部论文审稿周期
2 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
32
天
First-line pembrolizumab plus chemotherapy versus bevacizumab plus chemotherapy in response and survival outcomes in PD-L1-negative advanced non-squamous NSCLC: a retrospective comparative cohort study
作者
Kuofang Huang; Shifei Pan; Huishu Dong; Haijiao Lu; Bo Yan; Jialin Qian; Tianqing Chu展开收起
作者单位
1. Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;; 2. Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;; 3. Clinical Research Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China展开收起
50
天
PSMA6 drives non-small cell lung cancer progression by stabilizing NEDD8 and activating NF-κB signaling
作者
Shiyang Deng; Zixuan Li; Nan Liu; Yue Wang; Jialu Sun; Bin Guan; Jiang Du展开收起
作者单位
1. Department of Pathology, The First Affiliated Hospital of China Medical University, Shenyang, China;; 2. Department of Pathology, College of Basic Medical Science, China Medical University, Shenyang, China;; 3. Department of Clinical Nutrition, The First Affiliated Hospital of China Medical University, Shenyang, China;; 4. School of Stomatology, China Medical University, Shenyang, China;; 5. School of Health Management, China Medical University/Human Resources Department, The Third Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天